Saama Raises Up To $430M Investment

Funding Rounds

▤ Summary

Saama Technologies, Inc., a Campbell, Calif.-based AI-driven Intelligent Clinical Cloud company, received an up to $430m investment. The company intends to use the funds to accelerate its strategic initiatives, including expanding its go-to-market capabilities and further investing in AI research and development. Led by Suresh Katta, Founder and CEO, Saama provides the Life Science Analytics Cloud (LSAC), which is used by over 50 pharma and biotech companies on more than 1,500 studies. LSAC provides a unified approach to clinical trial data management and analytics. Its pre-trained AI embedded smart applications have the ability to learn the complex patterns among clinical data and provide predictive insights to accelerate the clinical research process across a variety of domains and therapeutic areas.

$ Funding

$
Amount - Total raised
□
Date - Announcement date
◎
Investors Saama Technologies Lead investors
▥
Company - Funded company

▥ Classifications

industries
HealthTech
applications
Business Intelligence

◇ AskAI Classifications

Labels
Artificial Intelligence Life Sciences Software SaaS

▦ Linked Companies

Saama
$100M to $250M